ITMI911101A1 - Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie - Google Patents

Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie

Info

Publication number
ITMI911101A1
ITMI911101A1 IT001101A ITMI911101A ITMI911101A1 IT MI911101 A1 ITMI911101 A1 IT MI911101A1 IT 001101 A IT001101 A IT 001101A IT MI911101 A ITMI911101 A IT MI911101A IT MI911101 A1 ITMI911101 A1 IT MI911101A1
Authority
IT
Italy
Prior art keywords
treatment
diseases
autoimmunitary
indazole
prepare
Prior art date
Application number
IT001101A
Other languages
English (en)
Inventor
Bruno Silvestrini
Original Assignee
Angelini Francesco Ist Ricerca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angelini Francesco Ist Ricerca filed Critical Angelini Francesco Ist Ricerca
Publication of ITMI911101A0 publication Critical patent/ITMI911101A0/it
Priority to ITMI911101A priority Critical patent/IT1253703B/it
Priority to EP92201037A priority patent/EP0510748B1/en
Priority to AT92201037T priority patent/ATE135573T1/de
Priority to DK92201037.6T priority patent/DK0510748T3/da
Priority to DE69209128T priority patent/DE69209128T2/de
Priority to US07/868,311 priority patent/US5278183A/en
Priority to AU14883/92A priority patent/AU657524B2/en
Priority to ZA922740A priority patent/ZA922740B/xx
Priority to CA002066304A priority patent/CA2066304C/en
Priority to NZ242392A priority patent/NZ242392A/en
Priority to IL10166092A priority patent/IL101660A/en
Priority to JP4102849A priority patent/JP3056879B2/ja
Priority to KR1019920006797A priority patent/KR100210199B1/ko
Priority to CS921227A priority patent/CZ280613B6/cs
Priority to SK1227-92A priority patent/SK278546B6/sk
Publication of ITMI911101A1 publication Critical patent/ITMI911101A1/it
Priority to BG098590A priority patent/BG61366B2/bg
Application granted granted Critical
Publication of IT1253703B publication Critical patent/IT1253703B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ITMI911101A 1991-04-22 1991-04-22 Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie IT1253703B (it)

Priority Applications (16)

Application Number Priority Date Filing Date Title
ITMI911101A IT1253703B (it) 1991-04-22 1991-04-22 Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
EP92201037A EP0510748B1 (en) 1991-04-22 1992-04-11 Use of a methoxy alkanoic acid of indazole for the manufacture of a medicament for the treatment of autoimmune diseases
AT92201037T ATE135573T1 (de) 1991-04-22 1992-04-11 Verwendung von indazol-methoxyalkansäure zur herstellung eines arzneimittels zur behandlung von autoimmunkrankheiten
DK92201037.6T DK0510748T3 (da) 1991-04-22 1992-04-11 Anvendelse af en methoxyalkansyre af indazol til fremstilling af et lægemiddel til behandling af autoimmune sygdomme
DE69209128T DE69209128T2 (de) 1991-04-22 1992-04-11 Verwendung von Indazol-Methoxyalkansäure zur Herstellung eines Arzneimittels zur Behandlung von Autoimmunkrankheiten
US07/868,311 US5278183A (en) 1991-04-22 1992-04-14 Method for the treatment of autoimmune diseases
AU14883/92A AU657524B2 (en) 1991-04-22 1992-04-14 Pharmeceutical composition for the treatment of autoimmune diseases
ZA922740A ZA922740B (en) 1991-04-22 1992-04-14 Pharmaceutical composition for the treatment of auto-immune diseses
CA002066304A CA2066304C (en) 1991-04-22 1992-04-16 Pharmaceutical composition for the treatment of autoimmune diseases
NZ242392A NZ242392A (en) 1991-04-22 1992-04-16 Pharmaceutical composition for treating autoimmune diseases comprising 1-benzyl-indazol-3-ylmethoxy-acetic or -2-alkanoic acid or their ester derivatives
IL10166092A IL101660A (en) 1991-04-22 1992-04-21 Pharmaceutical preparation for the treatment of the immune system
JP4102849A JP3056879B2 (ja) 1991-04-22 1992-04-22 自己免疫疾患処置のための医薬組成物
KR1019920006797A KR100210199B1 (ko) 1991-04-22 1992-04-22 자기면역질환요법을 위한 약제조성물
CS921227A CZ280613B6 (cs) 1991-04-22 1992-04-22 Farmaceutický prostředek pro léčení autoimunitních onemocnění
SK1227-92A SK278546B6 (en) 1991-04-22 1992-04-22 Pharmaceutical composition for healing autoimmune deseases
BG098590A BG61366B2 (bg) 1991-04-22 1994-02-25 Използване на съединения на метокси алифатните киселини с индазол за получаване на фармацевтично средство за лечение на автоимунни заболявания

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911101A IT1253703B (it) 1991-04-22 1991-04-22 Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie

Publications (3)

Publication Number Publication Date
ITMI911101A0 ITMI911101A0 (it) 1991-04-22
ITMI911101A1 true ITMI911101A1 (it) 1992-10-22
IT1253703B IT1253703B (it) 1995-08-23

Family

ID=11359721

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI911101A IT1253703B (it) 1991-04-22 1991-04-22 Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie

Country Status (16)

Country Link
US (1) US5278183A (it)
EP (1) EP0510748B1 (it)
JP (1) JP3056879B2 (it)
KR (1) KR100210199B1 (it)
AT (1) ATE135573T1 (it)
AU (1) AU657524B2 (it)
BG (1) BG61366B2 (it)
CA (1) CA2066304C (it)
CZ (1) CZ280613B6 (it)
DE (1) DE69209128T2 (it)
DK (1) DK0510748T3 (it)
IL (1) IL101660A (it)
IT (1) IT1253703B (it)
NZ (1) NZ242392A (it)
SK (1) SK278546B6 (it)
ZA (1) ZA922740B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2723315B1 (fr) 1994-08-02 1996-10-25 Cird Galderma Procede et composition pour stimuler la differenciation des cellules preadipocytaires et traitements therapeutiques associes
IT1276031B1 (it) * 1995-10-31 1997-10-24 Angelini Ricerche Spa Composizione farmaceutica per il trattamento delle malattie autoimmuni
IT1293795B1 (it) * 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
CA2464333C (en) * 2001-10-26 2011-07-26 University Of Connecticut Heteroindanes: a new class of potent cannabimimetic ligands
ITMI20062254A1 (it) * 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
AU2009221089B2 (en) 2008-03-07 2013-12-05 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40
KR101581829B1 (ko) 2008-03-07 2015-12-31 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 1-벤질-3-하이드록시메틸인다졸 유도체들 및 ｍｃｐ-1 및 ｃｘ3ｃｒ1의 발현을 기초로 한 질환들의 치료에서 이의 용도
LT2262778T (lt) 2008-03-07 2019-11-11 Acraf 1-benzil-3-hidroksimetilindazolo dariniai ir jų panaudojimas gydant ligas, pagrįstas mcp-1, cxcr1 ir p40 raiška
CN106518769A (zh) 2009-08-03 2017-03-22 方济各安吉利克化学联合股份有限公司 1‑苄基‑3‑羟甲基‑1h‑吲唑及其衍生物以及所需镁中间体的制备方法
UA108742C2 (uk) 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
US11753382B2 (en) 2019-06-25 2023-09-12 Translatum Medicus Inc. Processes of making 2-((1-benzyl-1H-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194564B (it) * 1983-04-18 1988-09-22 Acraf Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa
DE3664036D1 (en) * 1985-02-12 1989-07-27 Acraf (1-phenylmethyl-5-hydroxy-1h-indazol-3-yl)-oxyacetic acid and salts thereof for use as a medicament, and pharmaceutical compositions containing them
IT1230441B (it) * 1989-02-07 1991-10-23 Acraf Eteri della serie dell'indazolo

Also Published As

Publication number Publication date
EP0510748A1 (en) 1992-10-28
JPH0640915A (ja) 1994-02-15
CA2066304A1 (en) 1992-10-23
JP3056879B2 (ja) 2000-06-26
DK0510748T3 (da) 1996-07-22
DE69209128T2 (de) 1996-11-28
US5278183A (en) 1994-01-11
KR920019350A (ko) 1992-11-19
IT1253703B (it) 1995-08-23
EP0510748B1 (en) 1996-03-20
BG61366B2 (bg) 1997-06-30
ATE135573T1 (de) 1996-04-15
CZ280613B6 (cs) 1996-03-13
IL101660A (en) 1996-08-04
CS122792A3 (en) 1992-11-18
KR100210199B1 (ko) 1999-07-15
SK278546B6 (en) 1997-09-10
DE69209128D1 (de) 1996-04-25
CA2066304C (en) 2005-06-21
ZA922740B (en) 1992-12-30
ITMI911101A0 (it) 1991-04-22
AU1488392A (en) 1992-10-29
AU657524B2 (en) 1995-03-16
NZ242392A (en) 1997-06-24

Similar Documents

Publication Publication Date Title
NO176356C (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive pyrazolopyridinforbindelser
DE69206345D1 (de) Arzneimittel zur intranasalen Verabreichung, die Ketorolac R enthalten.
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
ITMI911101A1 (it) Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
NO855204L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylcyklobutylalkylaminer.
US5330978B1 (en) Phosphonic acid derivatives and use thereof
WO1999004770A3 (en) A pharmaceutical composition active in reducing production of mcp-1 protein
RU2001126063A (ru) Производные пиридазин-3-она и содержащие их лекарственные средства
KR910018348A (ko) 술포닐아미노치환 비시클로환계 히드록삼산 유도체
FI104071B1 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 2,5-dihydro-2,5-diokso-1H-bents[b]atsepiinijohdannaisten valmistamiseksi
FI920425A0 (fi) Cykloalkylenazoler, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska preparat och deras anvaendning vid framstaellning av laekemedel.
IT1211792B (it) O-alcanoil derivati dell'acido 3ammino-2-idrossipropansolfonico adattivita'anticonvulsivante e loro composizioni farmaceutiche per il trattamento terapeutico dell'epilessia
JPS6479186A (en) Ester substituted thienotriazolodiazepine compound and medicinal use thereof
ES8203896A1 (es) Procedimiento para preparar 2,3-dihidroimidazo(1,2-b)pirida-zinas
ZA939153B (en) Use of idazoxan and its derivatives for the preparation of a medicinal product intended for the treatment of parkinson's disease and its development
NO894325L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.
GB1440834A (en) Esters and amides for 3-aryl-1,4-benzodioxan-2-carboxylic acids
KR940002268A (ko) 21-클로로-프레그난 유도체
DK644487D0 (da) Farmaceutisk praeparat indeholdende en 2-oxo-imidazolidinforbindelse
DE3884878D1 (de) Uricosuretische Zusammensetzung.
GB1505859A (en) Azetidinone derivatives
DE69132036D1 (de) Wirkstoff zur Behandlung der Drogenabhängigkeit
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
TH13390EX (th) อนุพันธ์ของอินโดลและอินดาโซลสำหรับใช้รักษาและ ป้องกันผิดปกติเกี่ยวกับสมองใหญ่, การเตรียมและ การใช้สารเหล่านั้น
TH15020B (th) อนุพันธ์พิรโรโลคาร์บาโซล ซึ่งใช้เป็นสารเคมีรักษาโรค

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950426